Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Pseudostat enters phase II in CF patients

Aug. 16, 1996

LMA-Flexible introduced by Gensia

Aug. 16, 1996

SKB discloses drugs for IL-8-mediated disorders

Aug. 16, 1996

IL-8 role in emphysema and asthma suggested

Aug. 16, 1996

PDE IV inhibitors claimed by Euroceltique

Aug. 16, 1996

Roche Bioscience, LeukoSite to investigate drugs for allergy and asthma

Aug. 16, 1996

Ipratropium bromide relieves rhinorrhea, sneezing in cold patients

Aug. 16, 1996

Cyclohexapeptides with multiple utilities reported by Hoechst

Aug. 9, 1996

Serine protease inhibitors in Teijin's R&D pipeline

Aug. 9, 1996

Potent 5-lipoxygenase inhibitors from Yakult Honsha

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...